NDC Code(s) : 68084-837-11, 68084-837-21, 68084-837-95, 68084-837-25
Packager : American Health Packaging
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
Fluvoxamine MaleateFluvoxamine Maleate TABLET | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
PRINCIPAL DISPLAY PANEL
NDC 68084-837-25
Fluvoxamine Maleate
Tablets, USP
50 mg
30 Tablets (5 × 6)
PHARMACIST: Dispense with the accompanying
Medication Guide to each patient.
Each Tablet Contains:
Fluvoxamine maleate .........................................50 mg.
Usual dosage: See package insert for full
prescribing information.
Store at 20º to 25ºC (68º to 77ºF); excursions
permitted to 15º to 30ºC (59º to 86ºF) [see
USP Controlled Room Temperature]. Protect from
high humidity.
Keep this and all drugs out of reach of children.
FOR YOUR PROTECTION: Do not use if blister is
torn or broken.
Rx Only
The drug product contained in this package is from
NDC # 60505-0165, Apotex Corp.
Distributed by:
American Health Packaging
Columbus, Ohio 43217
083725
0283725/1015OS
PRINCIPAL DISPLAY PANEL
Fluvoxamine
Maleate
Tablet, USP
50 mg